Devillard Eric, Petillon Fanny, Rouzaire Marion, Pereira Bruno, Accoceberry Marie, Houlle Céline, Dejou-Bouillet Lydie, Bouchet Pamela, Delabaere Amélie, Gallot Denis
Department of Obstetrics and Gynecology, CHU Clermont-Ferrand, 63000 Clermont-Ferrand, France.
Department of Obstetrics and Gynecology, Lucien Hussel Hospital, 38209 Vienne, France.
J Clin Med. 2022 Mar 10;11(6):1525. doi: 10.3390/jcm11061525.
Background: The aim of this study is to demonstrate that a double balloon catheter combined with oxytocin decreases time between induction of labor and delivery (TID) as compared to a vaginal dinoprostone insert in cases of premature rupture of membranes at term. Methods: This is a prospective, randomized, controlled trial including patient undergoing labor induction for PROM at term with an unfavorable cervix in Clermont-Ferrand university hospital. We compared the double balloon catheter over a period of 12 h with adjunction of oxytocin 6 h after catheter insertion versus dinoprostone vaginal insert. After device ablation, cervical ripening continued only with oxytocin. The main outcome was TID. Secondary outcomes concerned delivery mode, as well as maternal and fetal outcome, and were adjusted for parity. Results: 40 patients per group were randomized. Each group had similar baseline characteristics. The study failed to demonstrate reduced TID (16.2 versus 20.2 h, ES = 0.16 (−0.27 to 0.60), p = 0.12) in the catheter group versus dinoprostone except in nulliparous women (17.0 versus 26.5 h, ES = 0.62 (0.10 to 1.14), p = 0.006). The rate of vaginal delivery <24 h significantly increased with combined induction (88.5% versus 66.6%, p = 0.03). No statistical difference was observed concerning caesarean rate (12.5% versus 17.5%, p > 0.05), chorioamnionitis (0% versus 2.5%, p = 1), postpartum endometritis, or maternal or neonatal outcomes. Procedure-related pain and tolerance to devices were found to be similar for the two methods. Interpretation: The double balloon catheter combined with oxytocin is an alternative for cervical ripening in case of PROM at term, and may reduce TID in nulliparous women.
本研究旨在证明,与足月胎膜早破病例中使用阴道地诺前列酮栓剂相比,双球囊导管联合缩宫素可缩短引产至分娩的时间(TID)。方法:这是一项前瞻性、随机、对照试验,纳入了克莱蒙费朗大学医院足月胎膜早破且宫颈条件不佳的引产患者。我们将双球囊导管放置12小时并在导管插入6小时后加用缩宫素与阴道放置地诺前列酮栓剂进行比较。器械取出后,仅用缩宫素促进宫颈成熟。主要结局指标是TID。次要结局指标包括分娩方式以及母胎结局,并根据产次进行了校正。结果:每组随机分配40例患者。每组的基线特征相似。研究未能证明导管组与地诺前列酮组相比TID缩短(16.2小时对20.2小时,效应量=0.16(-0.27至0.60),p=0.12),但初产妇除外(17.0小时对26.5小时,效应量=0.62(0.10至1.14),p=0.006)。联合引产使<24小时阴道分娩率显著增加(88.5%对66.6%,p=0.03)。剖宫产率(12.5%对17.5%,p>0.05)、绒毛膜羊膜炎(0%对2.5%,p=1)、产后子宫内膜炎或母胎结局方面未观察到统计学差异。发现两种方法的操作相关疼痛和对器械的耐受性相似。解读:双球囊导管联合缩宫素是足月胎膜早破时宫颈成熟的一种替代方法,可能会缩短初产妇的TID。